← Leaderboards
Edward A Fisher
Mount Sinai School Of Medicine Of Nyu
$34,926,928
Attributed
$42,763,485
Total exposure
22
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$65,055,448 · 23
By mechanism
P01$35,055,866 · 13
R01$29,999,582 · 10
Top collaborators
- Kathryn J Moore8 shared
- Ira Jay Goldberg6 shared
- Ana Rodriguez5 shared
- Sam Wassmer5 shared
- Michael J Garabedian4 shared
- Joseph M Miano4 shared
- Jeffrey L. Brodsky3 shared
- Png Loke3 shared
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Irwin H. Gelman$3,329,420
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisCellsMolecularMacrophagePathway InteractionsMouse ModelRegulationIn VitroMediatingLipidsBaseIn VivoPlasmaInflammatoryGene ExpressionArterial Fatty StreakProteinsTissuesLeadInsightMetabolicSiteBiologyCholesterol
Grant awards (105)
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases$2,567,925
P01 · FY2025 · HL · contact PI
Resolving Macrophage Inflammation in Atherosclerotic Plaques and Other Sites in Insulin Resistance$475,193
P01 · FY2025 · HL · contact PI
Novel regulatory mechanisms controlling hepatic apoB-Lp lipid loading and secretion$422,764
P01 · FY2025 · HL · contact PI
Administrative, Biostatistics, Data Management, and Bioinformatics Core$320,269
P01 · FY2025 · HL · contact PI
Atherosclerosis core$192,053
P01 · FY2025 · HL · contact PI
The role of FIT2 in VLDL assembly, hepatic triglyceride homeostasis, and lipoprotein atherogenicity$172,405
R01 · FY2025 · HL · contact PI
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases$2,516,567
P01 · FY2024 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression - Renewal$819,950
R01 · FY2024 · HL · contact PI
Resolving Macrophage Inflammation in Atherosclerotic Plaques and Other Sites in Insulin Resistance$528,322
P01 · FY2024 · HL · contact PI
Novel regulatory mechanisms controlling hepatic apoB-Lp lipid loading and secretion$473,104
P01 · FY2024 · HL · contact PI
Administrative, Biostatistics, Data Management, and Bioinformatics Core$340,882
P01 · FY2024 · HL · contact PI
Atherosclerosis core$193,969
P01 · FY2024 · HL · contact PI
The role of FIT2 in VLDL assembly, hepatic triglyceride homeostasis, and lipoprotein atherogenicity$168,957
R01 · FY2024 · HL · contact PI
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases$2,567,925
P01 · FY2023 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression - Renewal$836,684
R01 · FY2023 · HL · contact PI
Resolving Macrophage Inflammation in Atherosclerotic Plaques and Other Sites in Insulin Resistance$527,993
P01 · FY2023 · HL · contact PI
Novel regulatory mechanisms controlling hepatic apoB-Lp lipid loading and secretion$473,046
P01 · FY2023 · HL · contact PI
Administrative, Biostatistics, Data Management, and Bioinformatics Core$355,853
P01 · FY2023 · HL · contact PI
Atherosclerosis core$214,893
P01 · FY2023 · HL · contact PI
The role of FIT2 in VLDL assembly, hepatic triglyceride homeostasis, and lipoprotein atherogenicity$189,780
R01 · FY2023 · HL · contact PI
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases$2,567,925
P01 · FY2022 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression - Renewal$836,684
R01 · FY2022 · HL · contact PI
Resolving Macrophage Inflammation in Atherosclerotic Plaques and Other Sites in Insulin Resistance$527,993
P01 · FY2022 · HL · contact PI
Administrative, Biostatistics, Data Management, and Bioinformatics Core$355,853
P01 · FY2022 · HL · contact PI
Macrophage Dysfunction in Obesity, Diabetes and Atherosclerosis$2,409,733
P01 · FY2021 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression - Renewal$836,684
R01 · FY2021 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Atherosclerosis Regression in Diabetes$533,864
P01 · FY2021 · HL · contact PI
Administrative Core$225,231
P01 · FY2021 · HL · contact PI
Macrophage Dysfunction in Obesity, Diabetes and Atherosclerosis$2,430,175
P01 · FY2020 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Atherosclerosis Regression in Diabetes$536,661
P01 · FY2020 · HL · contact PI
Administrative Core$225,231
P01 · FY2020 · HL · contact PI
Macrophage Dysfunction in Obesity, Diabetes and Atherosclerosis$2,393,695
P01 · FY2019 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$629,209
R01 · FY2019 · HL · contact PI
HDL and atherosclerosis regression$610,246
R01 · FY2019 · HL
Macrophage Trafficking, Inflammation & Metabolism in Atherosclerosis Regression in Diabetes$530,304
P01 · FY2019 · HL · contact PI
Molecular Regulation of Apoprotein B Degradation$408,678
R01 · FY2019 · HL · contact PI
Administrative Core$225,231
P01 · FY2019 · HL · contact PI
Macrophage Dysfunction in Obesity, Diabetes and Atherosclerosis$2,410,830
P01 · FY2018 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$629,209
R01 · FY2018 · HL · contact PI
HDL and atherosclerosis regression$610,246
R01 · FY2018 · HL
Beta-catenin signaling in endothelial cells during cerebral malaria$546,908
R01 · FY2018 · HL
Macrophage Trafficking, Inflammation & Metabolism in Atherosclerosis Regression in Diabetes$530,304
P01 · FY2018 · HL · contact PI
Molecular Regulation of Apoprotein B Degradation$408,678
R01 · FY2018 · HL · contact PI
Administrative Core$225,232
P01 · FY2018 · HL · contact PI
Macrophage Dysfunction in Obesity, Diabetes and Atherosclerosis$2,427,188
P01 · FY2017 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$629,209
R01 · FY2017 · HL · contact PI
HDL and atherosclerosis regression$610,246
R01 · FY2017 · HL
Macrophage Trafficking, Inflammation & Metabolism in Atherosclerosis Regression in Diabetes$530,304
P01 · FY2017 · HL · contact PI
Regulation of LXR alpha by glucose & cholesterol in diabetes & atherosclerosis$504,906
R01 · FY2017 · HL
Beta-catenin signaling in endothelial cells during cerebral malaria$472,313
R01 · FY2017 · HL
Molecular Regulation of Apoprotein B Degradation$408,678
R01 · FY2017 · HL · contact PI
Administrative Core$242,607
P01 · FY2017 · HL · contact PI
Beta-catenin signaling in endothelial cells during cerebral malaria$87,265
R01 · FY2017 · HL
Molecular Regulation of Atherosclerosis Regression$629,209
R01 · FY2016 · HL · contact PI
HDL and atherosclerosis regression$610,246
R01 · FY2016 · HL
Diabetes-mediated effects on myeloid precursors and vascular complications$558,164
R01 · FY2016 · DK · contact PI
Regulation of LXR alpha by glucose & cholesterol in diabetes & atherosclerosis$520,698
R01 · FY2016 · HL
Regulation and Function of AKAP12A in the Vessel Wall$504,640
R01 · FY2016 · HL
Beta-catenin signaling in endothelial cells during cerebral malaria$483,899
R01 · FY2016 · HL
Molecular Regulation of Apoprotein B Degradation$426,053
R01 · FY2016 · HL · contact PI
Diabetes-mediated effects on myeloid precursors and vascular complications$617,182
R01 · FY2015 · DK · contact PI
Regulation of LXR alpha by glucose & cholesterol in diabetes & atherosclerosis$512,887
R01 · FY2015 · HL · contact PI
Beta-catenin signaling in endothelial cells during cerebral malaria$505,623
R01 · FY2015 · HL
Regulation and Function of AKAP12A in the Vessel Wall$497,069
R01 · FY2015 · HL
Molecular Regulation of Atherosclerosis Regression$579,689
R01 · FY2014 · HL · contact PI
HDL and Atherosclerosis Regression$538,265
P01 · FY2014 · HL · contact PI
Regulation of LXR alpha by glucose & cholesterol in diabetes & atherosclerosis$538,073
R01 · FY2014 · HL · contact PI
Regulation and Function of AKAP12A in the Vessel Wall$500,789
R01 · FY2014 · HL
Diabetes-Mediated Effects on Myeloid Precursors and Vascular Complications$345,885
R01 · FY2014 · DK · contact PI
Molecular Regulation of Apoprotein B Degradation$326,288
R01 · FY2014 · HL · contact PI
Regression of Atherosclerosis Core$165,619
P01 · FY2014 · HL · contact PI
Diabetes-mediated effects on myeloid precursors and vascular complications$59,018
R01 · FY2014 · DK · contact PI
Molecular Regulation of Atherosclerosis Regression$618,955
R01 · FY2013 · HL · contact PI
Diabetes-mediated effects on myeloid precursors and vascular complications$525,085
R01 · FY2013 · DK · contact PI
HDL and Atherosclerosis Regression$522,887
P01 · FY2013 · HL · contact PI
Regulation and Function of AKAP12A in the Vessel Wall$514,491
R01 · FY2013 · HL
Regression of Atherosclerosis Core$160,888
P01 · FY2013 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$650,162
R01 · FY2012 · HL · contact PI
Diabetes-mediated effects on myeloid precursors and vascular complications$561,379
R01 · FY2012 · DK · contact PI
HDL and Atherosclerosis Regression$549,250
P01 · FY2012 · HL · contact PI
Molecular Regulation of Apoprotein B Degradation$404,484
R01 · FY2012 · HL · contact PI
Regression of Atherosclerosis Core$169,000
P01 · FY2012 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$650,162
R01 · FY2011 · HL · contact PI
HDL and Atherosclerosis Regression$545,903
P01 · FY2011 · HL · contact PI
Molecular Regulation of Apoprotein B Degradation$408,570
R01 · FY2011 · HL · contact PI
Regression of Atherosclerosis Core$167,970
P01 · FY2011 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$671,902
R01 · FY2010 · HL · contact PI
HDL and Atherosclerosis Regression$566,934
P01 · FY2010 · HL · contact PI
Molecular Regulation of Apoprotein B Degradation$408,570
R01 · FY2010 · HL · contact PI
Regression of Atherosclerosis Core$170,031
P01 · FY2010 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$619,744
R01 · FY2009 · HL · contact PI
Molecular Regulation of Apoprotein B Degradation$425,945
R01 · FY2009 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$592,634
R01 · FY2008 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$590,150
R01 · FY2007 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$610,448
R01 · FY2006 · HL · contact PI
Molecular Regulation of Apoprotein B Degradation$347,732
R01 · FY2006 · HL · contact PI
Molecular Regulation of Apoprotein B Degradation$356,100
R01 · FY2005 · HL
Molecular Regulation of Apoprotein B Degradation$356,100
R01 · FY2004 · HL
Molecular Regulation of Apoprotein B Degradation$319,077
R01 · FY2003 · HL
Molecular Regulation of Apoprotein B Degradation$27,968
R01 · FY2003 · HL
Molecular Regulation of Apoprotein B Degradation$364,305
R01 · FY2002 · HL
HDL AND PLAQUES--NOVEL MODELS AND IMAGING TECHNIQUES$339,000
R01 · FY2001 · HL
MOLECULAR REGULATION OF APOPROTEIN B DEGRADATION$337,552
R01 · FY2001 · HL
HDL AND PLAQUES--NOVEL MODELS AND IMAGING TECHNIQUES$339,000
R01 · FY2000 · HL
MOLECULAR REGULATION OF APOPROTEIN B DEGRADATION$327,720
R01 · FY2000 · HL